Official notification to shareholders of matters to be brought to a vote (Proxy) - Form DEF 14A
Board of Directors
Frequently Asked Questions
Subscribe to Email Alerts
SEC Filing For null
CURE PHARMACEUTICAL HOLDING CORP. - DEF 14A (Filed: 13-12-2017)
Sub Document 1
2017 PROXY STATEMENT AND
Proposal #2: Advisory Vote to Approve Executive Compensation
Proposal #4. Ratification of Selection of Independent Auditor
Who is entitled to vote?
How are proxies voted?
What are the Board of Directors recommendations?
CURE Pharmaceutical Corporation
Code of Ethics
TRANSACTIONS WITH CERTAIN RELATED PERSONS
INFORMATION REGARDING THE EXECUTIVE OFFICERS OF THE COMPANY
PROPOSAL NO. 1 APPROVAL OF CURE PHARMACEUTICAL HOLDING CORP. S
Description of Principal Features of the 2017 Plan
Change in Capitalization
Stock Appreciation Rights
Certain U.S. Federal Income Tax Consequences
Nonqualified Stock Options
PROPOSAL NO. 4 RATIFICATION OF RBSM, LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING F
Outstanding Equity Awards At Fiscal Year-End
TABLE OF CONTENTS
CURE Pharmaceutical Holding Corp.
The Wall Street Journal
Committee Complying with Section 162(m).
Option or SAR Repricing.
Adjustments for Changes in Capital Structure.
Fair Market Value Limitation.
Payment of Exercise Price.
Exercisability and Term of SARs.
Restricted Stock Awards
Voting Rights; Dividends and Distributions.
Voting Rights, Dividend Equivalent Rights and Distributions.
Voting Rights; Dividend Equivalent Rights and Distributions.
Grant of Cash-Based Awards
Nontransferability of Cash-Based Awards and Other Stock-Based Awards.
Cash-Out of Outstanding Stock-Based Awards.
Compliance with Section 409A
Payment of Section 409A Deferred Compensation.
Payment Upon Death
Withholding in or Directed Sale of Shares.
Rights as a Stockholder.
IN WITNESS WHEREOF
PLAN HISTORY AND NOTES TO COMPANY
CURE PHARMACEUTICAL HOLDING CORP.
Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholde
Copyright © 2017
. All rights reserved.
Market Data powered by QuoteMedia,
, SEC filings by Morningstar.
IR website by